Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline and Aspirin in Poor Responders Undergoing ICSI-ET
NCT03263299Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Aug 2017
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of cabergoline, aspirin in female infertility, sponsored by Cairo University. Status: unknown.
02
Drugs
cabergolineaspirin
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03263299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03263299.